# clm_7D612B392881

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: total_equity  
value: 4,866,021,000 United States dollar  
valid_from: 2017-03-31  
valid_to: 2017-06-30  
published: 2017-05-04  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_A552A047999A  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals total equity: 4,866,021,000 United States dollar", as of 2017-03-31 (until 2017-06-30). Claim clm_7D612B392881, https://asof.is/claim/clm_7D612B392881, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000153217617000017/0001532176-17-000017-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q1 FY2017, filed 2017-05-04  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000153217617000017/0001532176-17-000017-index.htm (primary, SEC EDGAR 10-Q Q1 FY2017, published 2017-05-04)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 4,449,245,000 United States dollar | valid 2016-12-31 to 2017-03-31 | conf 0.95 | superseded | superseded_by [clm_7D612B392881](/claim/clm_7D612B392881.md) | [clm_33C916697C43](/claim/clm_33C916697C43.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.